Oncolytics Biotech Inc (ONCY) income statement
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)
Close on Nov 18, 2026Market cap $56.14MP/E –Yield –
Oncolytics Biotech Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?